• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

Covid vaccine: Scientists raise concern over risk of heart inflammation in young adults

Chidinma Anyalewechi by Chidinma Anyalewechi
October 18, 2021
in Socio Economic
Covid vaccine: Scientists raise concern over risk of heart inflammation in young adults
Share on FacebookShare on TwitterShare on Linkedin

Top scientists are still weighing whether to approve third doses of COVID-19 vaccine for anyone over 12 years as the risks of booster shots causing heart inflammation continues to be a source of concern.

This comment was made by a voting member of the Food and Drug Administration’s advisory panel, Dr. Ofer Levy, according to CBNC.

Dr. Levy, who is also the director of the Precision Vaccines Program at Boston Children’s Hospital, made the comment hours after second shots to all recipients of Johnson & Johnson’s single-dose Covid vaccine over 18 years old was unanimously recommended by the FDA’s Vaccines and Related Biological Products Advisory Committee.

RelatedStories

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 

September 26, 2024
moderna

Moderna pauses plans to build $500 million vaccine facility in Africa amid declining demand

April 11, 2024

What this means

Although, boosters from Moderna and Pfizer for all seniors and other high-risk groups has previously been recommended, some committee members have withheld their support for the authorization of third mRNA doses for people aged 12 and above due to the risk of two rare heart inflammation conditions, myocarditis and pericarditis as warned by scientists.

Dr. Levy said, “As we go into younger and younger age groups, they’re less and less at personal risk of severe Covid, and on the other hand, somewhat more at risk of this inflammatory heart condition with the mRNA vaccine. So, it’s a risk benefit analysis, and that’s why you’re seeing that deliberation.”

The Centers for Disease Control and Prevention has said the heart inflammation condition called myocarditis has been found mostly in male adolescents and young adults who received the Pfizer or Moderna vaccine and these complications arise within days of vaccination and usually happens after the second dose, however, it subsides when treated with medicine.

Studies also show that unlike the vaccines from Pfizer and Moderna, the Johnson & Johnson’s Covid shot is not associated with a risk for heart inflammation and over 15 million Americans have received the primary vaccine dose from J&J.

Tags: Covid vaccineDr. Ofer Levy.FDAModernaPfizerU.S. Food and Drug Administration
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Related Posts

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 
Health

Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide 

September 26, 2024
moderna
Health

Moderna pauses plans to build $500 million vaccine facility in Africa amid declining demand

April 11, 2024
Pfizer
Company News

Pfizer shares plunge 7% as 2024 revenue forecast falls below consensus estimates 

December 13, 2023
Pfizer loses $10 billion slice from obesity drug market as it discontinues its weight loss pill 
Health

Pfizer loses $10 billion slice from obesity drug market as it discontinues its weight loss pill 

December 5, 2023
Moderna
Health

Moderna Shares fall by 6.5% after reported loss in sales, production of Covid 19 vaccine

November 3, 2023
Hair relaxers
Health

FDA proposes ban on hair relaxers containing formaldehyde

October 25, 2023
Next Post
Piggyvest discounts claims they lost N2 billion to alleged fraud by Imagine Global Solution Limited

Piggyvest discounts claims they lost N2 billion to alleged fraud by Imagine Global Solution Limited

Comments 1

  1. C. I. Albert says:
    October 18, 2021 at 11:01 am

    The saturated outcome of this hasty innovation would come in about 3-5yrs time. No one is monitoring death by hunger; No one is monitoring death by Malaria and no one is ensuring Nobody goes to bed hungry but then, the Vaccine MUST be taken, the more they enforce it, the more the skeptism.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

first bank








DUNS

Recent News

  • Medical tourism: Why many Nigerians can no longer go abroad for treatment  – Olakunle Onakoya, Cedarcrest CEO
  • U.S introduces new immigration fees for asylum and work permit applicants, effective July 22 
  • Sabreworks celebrates excellence, rewards outstanding team members with life-changing awards

Follow us on social media:

Recent News

Medical tourism: Why many Nigerians can no longer go abroad for treatment  – Olakunle Onakoya, Cedarcrest CEO

Medical tourism: Why many Nigerians can no longer go abroad for treatment  – Olakunle Onakoya, Cedarcrest CEO

July 19, 2025
United States extends period for work permits for non-citizens

U.S introduces new immigration fees for asylum and work permit applicants, effective July 22 

July 19, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics